The role of imaging in the surveillance of urologic malignancies

Urol Clin North Am. 2006 Aug;33(3):377-96. doi: 10.1016/j.ucl.2006.03.001.

Abstract

Urologic malignancies are common, accounting for approximately 25% of all new cancer cases in the United States. Patients with urologic malignancies require long-term surveillance to detect progression or recurrence as early as possible. The urologist is faced with the task of balancing patient safety and cost-effectiveness, while finding the most practical follow-up regimen. For each urologic malignancy, this article reviews the commonly used radiologic techniques for surveillance and offers recommended follow-up schedules.

Publication types

  • Review

MeSH terms

  • Carcinoma, Renal Cell / diagnosis
  • Carcinoma, Renal Cell / therapy
  • Humans
  • Kidney Neoplasms / diagnosis
  • Kidney Neoplasms / therapy
  • Magnetic Resonance Imaging
  • Male
  • Population Surveillance
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / therapy
  • Testicular Neoplasms / diagnosis
  • Testicular Neoplasms / therapy
  • Tomography, X-Ray Computed
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / therapy
  • Urologic Neoplasms / diagnosis*
  • Urologic Neoplasms / therapy*